InvestSMART

Cynata Therapeutics Limited (ASX: CYP) - Announcements

- Current share price for CYP : $0.011

ASX company news and announcements for Cynata Therapeutics Limited (CYP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cynata Therapeutics Limited (CYP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cynata Therapeutics Limited (CYP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cynata Therapeutics Limited (CYP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$3 $5.2m placement of shares to Fidelity International 30 May 2018 9:45AM $1.250 $0.011 fallen by 99.12%
$3 Trading Halt 28 May 2018 10:26AM $1.250 $0.011 fallen by 99.12%
$3 Enrolment Completed in Cynata's Phase 1 Clinical Trial 24 May 2018 9:10AM $1.215 $0.011 fallen by 99.09%
$3 Cleansing Notice 22 May 2018 3:03PM $1.230 $0.011 fallen by 99.11%
$3 Appendix 3B-Exercise of Options 22 May 2018 3:02PM $1.230 $0.011 fallen by 99.11%
$3 Cleansing Notice 15 May 2018 5:24PM $1.390 $0.011 fallen by 99.21%
$3 Appendix 3B-Exercise of Options 15 May 2018 5:23PM $1.390 $0.011 fallen by 99.21%
$3 Becoming a substantial holder 7 May 2018 5:52PM $1.170 $0.011 fallen by 99.06%
$3 Notice of Allowance from EPO for Patent Application 7 May 2018 10:30AM $1.165 $0.011 fallen by 99.06%
$3 March 2018 Quarterly Report 27 Apr 2018 2:07PM $1.360 $0.011 fallen by 99.19%
$3 Cleansing Notice 24 Apr 2018 5:05PM $1.370 $0.011 fallen by 99.20%
$3 Appendix 3B-Exercise of Options 24 Apr 2018 5:02PM $1.370 $0.011 fallen by 99.20%
$3 CYP Completes Patent Application related to CAR-T Therapy 20 Apr 2018 9:38AM $1.390 $0.011 fallen by 99.21%
$3 Cyanta to Present at ARM Investor Day 12 Apr 2018 12:28PM $1.370 $0.011 fallen by 99.20%
$3 Further US Patent Granted for Cynata Cymerus Technology 11 Apr 2018 9:35AM $1.355 $0.011 fallen by 99.19%
$3 Cleansing Notice 4 Apr 2018 4:44PM $1.420 $0.011 fallen by 99.23%
$3 Appendix 3B-Exercise of Options 4 Apr 2018 4:43PM $1.420 $0.011 fallen by 99.23%
$3 Cleansing Notice 28 Mar 2018 3:45PM $1.445 $0.011 fallen by 99.24%
$3 Appendix 3B-Exercise of Options 28 Mar 2018 3:44PM $1.445 $0.011 fallen by 99.24%
$3 FDA Grants Orphan Drug Designation to Cyanta for CYP-001 28 Mar 2018 9:42AM $1.350 $0.011 fallen by 99.19%
$3 Cleansing Notice 13 Mar 2018 5:11PM $1.270 $0.011 fallen by 99.13%
$3 Appendix 3B-Exercise of Options 13 Mar 2018 5:11PM $1.270 $0.011 fallen by 99.13%
$3 Updated Top 20 Shareholders 13 Mar 2018 9:39AM $1.280 $0.011 fallen by 99.14%
$3 Shaw and Partners Updates Cynata Research Coverage 12 Mar 2018 9:48AM $1.190 $0.011 fallen by 99.08%
$3 Cleansing Notice 28 Feb 2018 5:55PM $1.155 $0.011 fallen by 99.05%

501 - 525 of 699 results

Page 21 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.